Literature DB >> 34888828

Neuroglia in Psychiatric Disorders.

Caterina Scuderi1, Alexei Verkhratsky2,3, Vladimir Parpura4, Baoman Li5.   

Abstract

In the twentieth century, neuropsychiatric disorders have been perceived solely from a neurone-centric point of view, which considers neurones as the key cellular elements of pathological processes. This dogma has been challenged thanks to the better comprehension of the brain functioning, which, even if far from being complete, has revealed the complexity of interactions that exist between neurones and neuroglia. Glial cells represent a highly heterogeneous population of cells of neural (astroglia and oligodendroglia) and non-neural (microglia) origin populating the central nervous system. The variety of glia reflects the innumerable functions that glial cells perform to support functions of the nervous system. Aberrant execution of glial functions contributes to the development of neuropsychiatric pathologies. Arguably, all types of glial cells are implicated in the neuropathology; however, astrocytes have received particular attention in recent years because of their pleiotropic functions that make them decisive in maintaining cerebral homeostasis. This chapter describes the multiple roles of astrocytes in the healthy central nervous system and discusses the diversity of astroglial responses in neuropsychiatric disorders suggesting that targeting astrocytes may represent an effective therapeutic strategy.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Astrocyte; Astrogliopathy; Homeostatic functions; Microglia; NG-2 glia; Neuroglia; Neuropsychiatric disorders; Oligodendrocytes

Mesh:

Year:  2021        PMID: 34888828      PMCID: PMC9063382          DOI: 10.1007/978-3-030-77375-5_1

Source DB:  PubMed          Journal:  Adv Neurobiol


  126 in total

1.  Layer V cortical neurons require microglial support for survival during postnatal development.

Authors:  Masaki Ueno; Yuki Fujita; Tatsuhide Tanaka; Yuka Nakamura; Junichi Kikuta; Masaru Ishii; Toshihide Yamashita
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

Review 2.  Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.

Authors:  Ileana Micu; Jason R Plemel; Andrew V Caprariello; Klaus-Armin Nave; Peter K Stys
Journal:  Nat Rev Neurosci       Date:  2017-11-09       Impact factor: 34.870

Review 3.  Na+-dependent transporters: The backbone of astroglial homeostatic function.

Authors:  Alexei Verkhratsky; Christine R Rose
Journal:  Cell Calcium       Date:  2019-12-03       Impact factor: 6.817

4.  Alexander disease.

Authors:  Albee Messing; Michael Brenner; Mel B Feany; Maiken Nedergaard; James E Goldman
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

5.  Protective role of reactive astrocytes in brain ischemia.

Authors:  Lizhen Li; Andrea Lundkvist; Daniel Andersson; Ulrika Wilhelmsson; Nobuo Nagai; Andrea C Pardo; Christina Nodin; Anders Ståhlberg; Karina Aprico; Kerstin Larsson; Takeshi Yabe; Lieve Moons; Andrew Fotheringham; Ioan Davies; Peter Carmeliet; Joan P Schwartz; Marcela Pekna; Mikael Kubista; Fredrik Blomstrand; Nicholas Maragakis; Michael Nilsson; Milos Pekny
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-29       Impact factor: 6.200

6.  Endocannabinoids mediate neuron-astrocyte communication.

Authors:  Marta Navarrete; Alfonso Araque
Journal:  Neuron       Date:  2008-03-27       Impact factor: 17.173

Review 7.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

Review 8.  The glial perspective of autism spectrum disorders.

Authors:  Fares Zeidán-Chuliá; Alla B Salmina; Natalia A Malinovskaya; Mami Noda; Alexei Verkhratsky; José Cláudio Fonseca Moreira
Journal:  Neurosci Biobehav Rev       Date:  2013-12-01       Impact factor: 8.989

Review 9.  On Myelinated Axon Plasticity and Neuronal Circuit Formation and Function.

Authors:  Rafael G Almeida; David A Lyons
Journal:  J Neurosci       Date:  2017-10-18       Impact factor: 6.167

10.  Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.

Authors:  Maria Rosanna Bronzuoli; Roberta Facchinetti; Luca Steardo; Adele Romano; Claudia Stecca; Sergio Passarella; Luca Steardo; Tommaso Cassano; Caterina Scuderi
Journal:  Oxid Med Cell Longev       Date:  2018-01-16       Impact factor: 6.543

View more
  2 in total

1.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

Review 2.  Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications.

Authors:  Marta Valenza; Roberta Facchinetti; Luca Steardo; Caterina Scuderi
Journal:  Biomolecules       Date:  2022-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.